| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | -13.3% |
| Cost of Revenue | $4.1M | -16.9% |
| Gross Profit | $1.1M | +4.6% |
| R&D Expense | $1.2M | -14.3% |
| SG&A Expense | $2.9M | -5.5% |
| Operating Income | -$2.9M | +13.4% |
| Pre-tax Income | -$2.0M | +24.5% |
| Net Income | -$2.0M | +24.3% |
| EPS (Basic) | -$0.32 |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | -35.0% |
| Accounts Receivable | $416K | -47.5% |
| Inventory | $3.6M | -11.1% |
| Current Assets | $6.0M | -21.5% |
| Total Assets | $11.1M | -17.2% |
| Current Liabilities | $7.0M | -27.6% |
| Long-term Debt | $3.7M | -41.5% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$365K | +62.9% |
| Capital Expenditures | $123K | -38.5% |
| Investing Cash Flow | -$101K | +68.5% |
| Financing Cash Flow | -$449K | +1.5% |
| Free Cash Flow | -$488K | +58.8% |
| +41.8% |
| EPS (Diluted) | -$0.32 | +41.8% |
| Total Liabilities |
| $8.9M |
| -27.5% |
| Stockholders' Equity | $2.2M | +91.2% |